Author:
Montero Alberto J.,McCarthy John J.,Chen George,Rice Lawrence
Publisher
Springer Science and Business Media LLC
Reference23 articles.
1. Charpentier B, Hiesse C, Ferran C, et al. Acute clinical syndrome associated with OKT3 administration: prevention by single injection of an anti-human TNF monoclonal antibody [in French]. Presse Med. 1991;20:2009-2011.
2. Charpentier B, Hiesse C, Lantz O, et al. Evidence that antihuman tumor necrosis factor monoclonal antibody prevents OKT3-induced acute syndrome. Transplantation. 1992;54:997-1002.
3. Hanauer SB. Review article: safety of infliximab in clinical trials. Aliment Pharmacol Ther. 1999;13(suppl 4):16-22.
4. Frey DJ, Matas AJ, Gillingham KJ, et al. Sequential therapy: a prospective randomized trial of MALG versus OKT3 for prophylactic immunosuppression in cadaver renal allograft recipients. Transplantation. 1992;54:50-56.
5. Bamgbola FO, Del Rio M, Kaskel FJ, Flynn JT. Non-cardiogenic pulmonary edema during basiliximab induction in three adolescent renal transplant patients. Pediatr Transplant. 2003;7:315-320.
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献